Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,250 | 44 | 77.1% |
| Travel and Lodging | $14,400 | 84 | 14.0% |
| Consulting Fee | $5,426 | 3 | 5.3% |
| Food and Beverage | $3,691 | 91 | 3.6% |
| Education | $8.47 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $64,596 | 116 | $0 (2018) |
| Allergan Inc. | $18,956 | 61 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,514 | 17 | $0 (2018) |
| Alkermes, Inc. | $5,506 | 9 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $1,761 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $977.17 | 3 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $235.07 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $163.12 | 10 | $0 (2019) |
| Lundbeck LLC | $47.72 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $18.85 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $423.04 | 17 | Allergan Inc. ($208.28) |
| 2018 | $64,647 | 121 | Otsuka America Pharmaceutical, Inc. ($43,615) |
| 2017 | $37,704 | 86 | Otsuka America Pharmaceutical, Inc. ($20,981) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: CNS | ||||||
| 09/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CNS | ||||||
| 08/09/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: CNS | ||||||
| 07/15/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: CNS | ||||||
| 06/27/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $106.45 | General |
| Category: Neuroscience | ||||||
| 04/08/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: CNS | ||||||
| 02/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CNS | ||||||
| 12/06/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,592.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $780.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $91.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2018 | Allergan Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $175.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $133.75 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 39 | 48 | $6,000 | $2,795 |
| 2022 | 1 | 60 | 158 | $19,750 | $10,410 |
| 2021 | 1 | 54 | 146 | $18,250 | $10,222 |
| 2020 | 1 | 55 | 138 | $17,250 | $7,664 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 48 | $6,000 | $2,795 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 158 | $19,750 | $10,410 | 52.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 146 | $18,250 | $10,222 | 56.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 138 | $17,250 | $7,664 | 44.4% |
About Dr. Patricia Paddison, M.D
Dr. Patricia Paddison, M.D is a Psychiatry healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750475307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Paddison, M.D has received a total of $102,774 in payments from pharmaceutical and medical device companies, with $423.04 received in 2019. These payments were reported across 224 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,250).
As a Medicare-enrolled provider, Paddison has provided services to 208 Medicare beneficiaries, totaling 490 services with total Medicare billing of $31,092. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Bellevue, WA
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750475307
Products in Payments
- REXULTI (Drug) $64,603
- VRAYLAR (Drug) $18,947
- Trintellix (Drug) $12,079
- INGREZZA (Drug) $235.07
- Entyvio (Biological) $196.20
- LATUDA (Drug) $163.12
- SPRAVATO (Drug) $106.45
- TRINTELLIX (Drug) $24.92
- AUSTEDO (Drug) $18.85
- ABILIFY MAINTENA (Drug) $15.60
- LINZESS (Drug) $8.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bellevue
Dr. Arifulla Khan, Md, MD
Psychiatry — Payments: $457,425
Dr. Mary-Ann Bolte, M.d, M.D
Psychiatry — Payments: $5,055
Deborah Haynes, Md, MD
Psychiatry — Payments: $2,575
Dr. Eugene Oliveto, Md, MD
Psychiatry — Payments: $2,494
Tatjana Deretic, M.d, M.D
Psychiatry — Payments: $1,806
Russell Vandenbelt, M.d, M.D
Psychiatry — Payments: $1,310